Home > Financial Ratios > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 26.6019.6619.3818.6216.82

What is the latest EV/Core EBITDA ratio of TORRENT PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of TORRENT PHARMACEUTICALS is 26.60 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202426.60
Mar202319.66
Mar202219.38
Mar202118.62
Mar202016.82

How is EV/Core EBITDA of TORRENT PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 26.6
35.30
Mar2023 19.66
1.44
Mar2022 19.38
4.08
Mar2021 18.62
10.70
Mar2020 16.82 -

Other Financial Ratios of TORRENT PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹112,492.6 Cr 2.1% 2.9% 31.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,960.0 Cr 3.1% 3.1% 17.5% Stock Analytics
DIVIS LABORATORIES ₹165,003.0 Cr 10.2% 6.7% 61.3% Stock Analytics
CIPLA ₹125,289.0 Cr 2.4% 2.5% 14% Stock Analytics
MANKIND PHARMA ₹107,386.0 Cr 0.8% 15.9% 9% Stock Analytics
DR REDDYS LABORATORIES ₹100,256.0 Cr 3.2% 1.3% -0.2% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

2.1%

2.9%

31.4%

SENSEX

3.6%

5.8%

10.1%


You may also like the below Video Courses